We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antibiotic-Resistant Gene Discovered in Salmonella

By LabMedica International staff writers
Posted on 05 Jun 2017
A team of investigators has discovered a gene, named fosA7, which confers a high level of resistance to the important broad-spectrum antibiotic fosfomycin. More...
The researchers found fosA7 in isolates of the pathogen Salmonella enterica from broiler chickens.

Fosfomycin has been a safe and effective agent for eliminating infections caused by multidrug-resistant bacteria. The product of fosA7 is the enzyme glutathione-S-transferase, which inactivates fosfomycin by binding to it and rupturing a molecular ring its structure. The “7” in fosA7 indicates that this is the seventh antibiotic resistant fosA gene that has been discovered.

“Vigilant monitoring for the spread of fosfomycin resistance in bacteria, isolated from humans and animals, is needed,” said corresponding author Moussa S. Diarra, PhD, research scientist at from Agriculture and Agri-Food Canada (AAFC; Guelph, Ontario, Canada). Currently, there is only limited fosfomycin resistance among Salmonella species. But the powerful resistance the fosA7 gene confers is worrisome, said Dr. Diarra. It could spread via horizontal gene transfer among different Salmonella serovar strains as well as other to bacterial pathogens, due to increased use of fosfomycin in both clinical and veterinary settings.

With that in mind, the researchers tested the strength of the resistance that fosA7 could confer on the closely related Salmonella enterica serovar Enteritidis by inserting the gene into the chromosome of non-antibiotic-resistant S. Enteriditis. Their worries were confirmed: the gene boosted the minimum concentration of fosfomycin required to inhibit microbe reproduction by more than 256-fold.

These results provided strong support for the hypothesis that fosA7 confers fosfomycin resistance, and that if fosA7 were transferred to plasmids it could induce a high level of resistance in recipient bacterial strains.

Fosfomycin resistance genes are often present in multidrug resistant bacteria. “This could further challenge the use of fosfomycin as an alternative treatment approach against urinary tract infections caused by both multidrug resistant E. coli, and blood infections from multidrug resistant Salmonella,” said Dr. Diarra.

The investigators have thus far found fosA7 only on S. enterica serovar Heidelberg and three other serovar strains. In the current study, they found fosA7 in all 15 Salmonella Heidelberg isolates in their collection. Salmonella enterica serovar Heidelberg is among the most common causes of human salmonellosis worldwide. The rise of resistance to multiple antibiotics, particularly to extended-spectrum cephalosporins, has limited the number of therapeutic options against this Salmonella serovar.

The study, by Rehman MA et al, was published May 22, 2017, in the journal Antimicrobial Agents and Chemotherapy.

Related Links
Agriculture and Agri-Food Canada


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.